CG
COLL icon

Cutler Group’s Collegium Pharmaceutical COLL Stock Holding History

Cutler Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,500
Closed -$25K – 4112
2018
Q4 		$25K Sell
1,500
-200
-12% -$3.42K ﹤0.01% 1945
2018
Q3 		$25K Sell
1,700
-100
-6% -$1.77K ﹤0.01% 2092
2018
Q2 		$42K Sell
1,800
-4,800
-73% -$118K ﹤0.01% 1715
2018
Q1 		$168K Buy
6,600
+2,000
+43% +$47.7K 0.01% 910
2017
Q4 		$84K Buy
4,600
+4,300
+1,433% +$61.6K ﹤0.01% 1494
2017
Q3 		$3K Buy
300
+100
+50% +$1.1K ﹤0.01% 4751
2017
Q2 		$2K Sell
200
-400
-67% -$3.95K ﹤0.01% 5457
2017
Q1 		$6K Sell
600
-600
-50% -$8.92K ﹤0.01% 4518
2016
Q4 		$18K Buy
+1,200
New +$19.9K ﹤0.01% 3555

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Cutler Group's COLL Position: Q1 2019 in Review

Cutler Group sold out of Collegium Pharmaceutical (COLL) in Q1 2019, closing a stake of 1,500 shares — an estimated $25K sold.

Cutler Group first reported a position in COLL in Q4 2016 and held it in 9 quarters. The position peaked at $168K in Q1 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

  • Cutler Group reported no remaining Collegium Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 1,500 Collegium Pharmaceutical shares in Q1 2019, an estimated $25K.
  • Cutler Group first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 9 quarters.
  • Cutler Group's Collegium Pharmaceutical position peaked at $168K in Q1 2018.
  • 145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.